Sublingual immunotherapy: A focused allergen immunotherapy practice parameter update

Matthew Greenhawt, John Oppenheimer, Michael Nelson, Hal Nelson, Richard Lockey, Phil Lieberman, Anna Nowak-Wegrzyn, Anju Peters, Charlotte Collins, David I. Bernstein, Joann Blessing-Moore, David Khan, David Lang, Richard A. Nicklas, Jay M. Portnoy, Christopher R. Randolph, Diane E. Schuller, Sheldon L. Spector, Stephen A. Tilles, Dana Wallace

Research output: Contribution to journalArticle

25 Scopus citations
Original languageEnglish (US)
Pages (from-to)276-282.e2
JournalAnnals of Allergy, Asthma and Immunology
Volume118
Issue number3
DOIs
StatePublished - Mar 1 2017

ASJC Scopus subject areas

  • Immunology and Allergy
  • Pulmonary and Respiratory Medicine

Cite this

Greenhawt, M., Oppenheimer, J., Nelson, M., Nelson, H., Lockey, R., Lieberman, P., Nowak-Wegrzyn, A., Peters, A., Collins, C., Bernstein, D. I., Blessing-Moore, J., Khan, D., Lang, D., Nicklas, R. A., Portnoy, J. M., Randolph, C. R., Schuller, D. E., Spector, S. L., Tilles, S. A., & Wallace, D. (2017). Sublingual immunotherapy: A focused allergen immunotherapy practice parameter update. Annals of Allergy, Asthma and Immunology, 118(3), 276-282.e2. https://doi.org/10.1016/j.anai.2016.12.009